Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …

Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …

Objective To develop an instrument to evaluate the credibility of anchor based minimal
important differences (MIDs) for outcome measures reported by patients, and to assess the …

Objectives To identify credible anchor-based minimal important differences (MIDs) for
patient-reported outcome measures (PROMs) relevant to a BMJ Rapid Recommendations …

Objectives The objective of the study was to develop an inventory summarizing all anchor-
based minimal important difference (MID) estimates for patient-reported outcome measures …

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19:
systematic review and network meta-analysis - PMC Back to Top Skip to main content NIH …

Background To summarise specific adverse effects of remdesivir, hydroxychloroquine and
lopinavir/ritonavir in patients with COVID-19. Methods We searched 32 databases through …